Skip to main content
. 2015 Nov 25;70(4):517–522. doi: 10.1038/ejcn.2015.200

Table 1. Baseline characteristics of the study sample and nested subgroup.

Variable All participants (n=4116) Nested participants with follow-up measurements (n=271)
25-Hydroxyvitamin D level (nmol/l) 59.4±20.3 65.9±21.4
Age (years) 61.8±10.4 60.8±10.2
Male sex, n (%) 2960 (71.9) 218 (80.4)
     
Study site, n (%)
 Bergen 3369 (81.9) 271 (100)
 Stavanger 747 (18.1)
Smoking, n (%) 1301 (31.7) 82 (30.3)
Body mass index (kg/m2) 26.8±4.0 26.9±3.4
C-reactive protein ⩾10 mg/l, n (%) 278 (6.8) 13 (4.8)
Physical activity ⩾2 h per week, n (%) 2135 (68.8) 185 (70.3)
Vitamin D supplements regularly or daily, n (%) 1191 (33.6) 98 (37.5)
Diabetes mellitus type 1 or 2, n (%) 491 (11.9) 29 (10.7)
Hypertension, n (%) 1928 (46.8) 121 (44.6)
Systolic blood pressure, mm Hg 141±20.8 142±21.6
Estimated glomerular filtration rate, ml/min per 1.732 87.8±17.2 90.9±14.6
Hypercholesterolaemia, n (%) 2228 (57.9) 162 (62.8)
Statin therapy, n (%) 2982 (72.4) 226 (83.4)
     
Extent of coronary artery disease
 No stenotic vessels 1035 (25.1)
 One vessel 952 (23.1) 137 (50.6)
 ⩾Two vessels 2129 (51.7) 134 (49.4)

Continuous variables are presented as mean±s.d. and categorical variables as numbers (n) and percentages (%). Missing values: smoking (n=7), BMI (n=3), systolic blood pressure (n=12), hypercholesterolaemia (n=267), physical activity level (n=1015), C-reactive protein (n=1), estimated glomerular filtration rate (n=3) and vitamin D supplement use (n=523).

Abbreviation: BMI, body mass index.